✦ LIBER ✦

Investigation of urinary transforming growth factor alpha levels as tumor markers in patients with advanced squamous cell carcinoma of the head and neck

✍ Scribed by Mary Fazekas-May; Dr. James Y. Suen; Yun Chi Yeh; Hsing Wu Yeh; Lynda Beth Milligan

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 436 KB
Volume: 12
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.2880120507

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The objective of this study was to determine whether transforming growth factor alpha (TGF alpha) levels could be used as nonspecific tumor markers in patients with advanced squamous cell carcinoma (SCC) of the head and neck. Fourteen patients with epidermoid carcinoma of the head and neck were followed with serial urine TGF alpha levels, and the results were compared with the extent of cancer and the course of the disease. Based on the findings of this study further research is necessary before urine TGF levels can be recommended as a routine screening test for SCC of the head and neck.

📜 SIMILAR VOLUMES

A pilot study of longitudinal serum cyto

A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma

✍ Colleen H. Druzgal; Zhong Chen; Ning T. Yeh; Giovana R. Thomas; Frank G. Ondrey; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 1 views

## Background: Head and neck squamous cell carcinomas (hnsccs) were previously shown to express a repertoire of cytokines and angiogenesis factors that contribute to malignant pathogenesis and are detectable in serum. pretreatment and posttreatment serum levels of cytokines and angiogenesis factors

Detection of synchronous lung tumors in

Detection of synchronous lung tumors in patients presenting with squamous cell carcinoma of the head and neck

✍ Samit K. Ghosh; Nicholas J. Roland; Aman Kumar; Sankalap Tandon; Jeffrey L. Lanc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

## Abstract ## __Background.__ Screening for synchronous pulmonary tumors in patients presenting with squamous cell carcinoma of the head and neck (SCCHN) is important, because detection may alter subsequent management. ## __Methods.__ We conducted a retrospective review, comparing effectiveness

Staging of head and neck squamous cell c

Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases

✍ Giorgio Cortesina; Tiziana Martone; Emanuela Galeazzi; Martina Olivero; Antonell 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 347 KB 👁 2 views

In head and neck squamous cell carcinomas (HNSCC), metastasis to cervical lymph nodes is a major determinant of patient outcome. To detect metastases, we used the MET oncogene as marker, which encodes the receptor for hepatocyte growth factor/scatter factor, mediating epithelial cell motility and in

Pilot study of intraoperative chemothera

Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck

✍ Ozlem E. Tulunay; Ileana I. Enamorado; Omer Kucuk; Lance K. Heilbrun; Jose E. Ot 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 3 views

## Abstract ## Background. Intraoperative manipulation of the tumor during cancer surgery has long been recognized as a source of metastasis and contamination of the surgical wound during tumor removal. We explored the use of intraoperative chemotherapy to minimize the risk of tumor cell implantat

High serum levels of YKL-40 in patients

High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival

✍ Anne Roslind; Julia S. Johansen; Ib J. Christensen; Katalin Kiss; Eva Balslev; D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 273 KB 👁 1 views

## Abstract YKL‐40 is a glycoprotein secreted by macrophages, neutrophils and malignant tumor cells. Elevated serum levels of YKL‐40 are associated with poor prognosis in several malignancies. In this study, we examined the prognostic value of serum YKL‐40 before treatment and during follow‐up in p

Evaluation of 96-hour infusion fluoroura

Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck. A southwest oncology group study

✍ Maha Hussain; Jacqueline Benedetti; Roy E. Smith; Gladys I. Rodriguez; David Sch 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views